Home / Letter From The Editor / Nov. 10, 2018

Nov. 10, 2018

Nov 10, 2018

Now that the Mid-term elections are, for all purposes, over with, we all know that there has been a change in leadership in the Congress. High on Congress’s agenda is the high cost of prescription drug prices, and we expect to see some pressure from the House to lower these costs. This could be great news for our patients who take insulin, as the price of insulin has skyrocketed over the past 10 years.

We know that the government sometimes moves slowly to make changes, but it appears that Sanofi may have a solution that our patients can take advantage of now! They are expanding their Insulin VALyou Savings program to include more patients. Check out Item #4 to see which of your patients can benefit.


Hopefully this will be the start of a trend that other insulin manufacturers will follow.



We can make a difference!


Dave Joffe